TOMI Environmental Solutions, Inc. logo

TOMI Environmental Solutions, Inc.

TOMZ

NASDAQIndustrialsIndustrial - Pollution & Treatment Controls

Regular session

$1.74

−$0.02 · -1.14%

Aug 24, 12:04 PM ET

TOMZ company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

39

Expensive

Momentum

42

Neutral

Sentiment

62

Bullish

Risk resilience

29

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

TOMI Environmental Solutions, Inc. is a company dedicated to controlling infectious diseases and decontaminating bacteria, offering sophisticated environmental solutions for sanitizing indoor surfaces globally and across the United States. Central to their operations is the development, sale, and licensing of SteraMist Binary Ionization Technology, which utilizes a hydrogen peroxide-based mist and fog for highly effective disinfection. Their diverse product lineup includes: The SteraMist Surface Unit, a portable, handheld device designed for quick, targeted disinfection of specific areas. The SteraMist Environment System, a transportable and remotely operated unit capable of completely disinfecting sealed rooms up to approximately 103.8 cubic meters. The SteraMist Hospital Disinfection Cart, specifically tailored for healthcare clients to elevate patient care and safety by decontaminating patient rooms, operating theaters, pharmacies, ambulances, and emergency zones within hospitals and other medical settings. Further offerings comprise the SteraMist Select Surface Unit, a Stainless Steel 90-Degree Applicator, the iHP Plasma Decontamination Chamber, and bespoke SteraMist Custom Engineered Systems. TOMI also provides iHP Corporate Service Decontamination, delivering comprehensive disinfection and decontamination services for entire rooms, equipment, facilities, and emergency situations. TOMI's advanced products and services are adopted across a broad spectrum of industries and settings. These range from hospitals, medical facilities, bio-safety labs, and pharmaceutical manufacturing plants to meat and produce processing facilities, universities, research institutions, and vivarium labs. Their solutions also extend to various service sectors like cruise ships, corporate offices, hotels, schools, restaurants, military barracks, police and fire departments, correctional facilities, and athletic venues, as well as residential properties including single-family homes and multi-unit dwellings. The company was established in 1979 and is based in Frederick, Maryland.

Industry
Industrial - Pollution & Treatment Controls
Sector
Industrials
Headquarters
US
CEO
Halden Stuart Shane
Listed since
Jun 20, 2008
Employees
20

Market position

Day range

Current $1.74

52-week range

Current $1.74

Open
$1.9363
Previous close
$1.76
Volume
7.99K
0.05× average
Average volume
164.58K
Average daily volume
Market cap
13.4M USD
Beta
1.98
Market reference 1
50-day average
$2.0234
-14.01% below average
200-day average
$2.1712
-19.86% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
19.01M USD
P/E (TTM)
-3.37×
P/B (TTM)
9.25×
P/S (TTM)
1.93×
EV / EBITDA
-6.78×
Earnings yield
-23.93%
Free cash flow yield
-8.50%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
50.42%
Operating margin
-40.95%
Net margin
-49.77%
Return on equity
-637.04%
Return on assets
-53.30%
Return on invested capital
-96.00%

Financial health

Debt / equity
2.38×
Current ratio
1.32×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends74%22%-30%-81%Gross margin, FY2021: 59.16%Gross margin, FY2022: 60.69%Gross margin, FY2023: 58.32%Gross margin, FY2024: 45.96%Gross margin, FY2025: 54.60%Operating margin, FY2021: -63.51%Operating margin, FY2022: -34.56%Operating margin, FY2023: -45.54%Operating margin, FY2024: -53.04%Operating margin, FY2025: -68.39%Net margin, FY2021: -57.21%Net margin, FY2022: -34.52%Net margin, FY2023: -46.27%Net margin, FY2024: -57.85%Net margin, FY2025: -66.52%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 59.16%. Gross margin FY2022 60.69%. Gross margin FY2023 58.32%. Gross margin FY2024 45.96%. Gross margin FY2025 54.60%. Operating margin FY2021 -63.51%. Operating margin FY2022 -34.56%. Operating margin FY2023 -45.54%. Operating margin FY2024 -53.04%. Operating margin FY2025 -68.39%. Net margin FY2021 -57.21%. Net margin FY2022 -34.52%. Net margin FY2023 -46.27%. Net margin FY2024 -57.85%. Net margin FY2025 -66.52%.

Income trends

Revenue

5.64M USD-27.17%

Operating income

−3.85M USD+6.10%

Net income

−3.75M USD+16.26%
Income trends across reported periods9.66M USD4.36M USD−945.52K USD−6.25M USDRevenue, FY2021: 7.75M USDRevenue, FY2022: 8.34M USDRevenue, FY2023: 7.35M USDRevenue, FY2024: 7.74M USDRevenue, FY2025: 5.64M USDOperating income, FY2021: −4.92M USDOperating income, FY2022: −2.88M USDOperating income, FY2023: −3.35M USDOperating income, FY2024: −4.1M USDOperating income, FY2025: −3.85M USDNet income, FY2021: −4.44M USDNet income, FY2022: −2.88M USDNet income, FY2023: −3.4M USDNet income, FY2024: −4.48M USDNet income, FY2025: −3.75M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 7.75M USD. Revenue FY2022 8.34M USD. Revenue FY2023 7.35M USD. Revenue FY2024 7.74M USD. Revenue FY2025 5.64M USD. Operating income FY2021 −4.92M USD. Operating income FY2022 −2.88M USD. Operating income FY2023 −3.35M USD. Operating income FY2024 −4.1M USD. Operating income FY2025 −3.85M USD. Net income FY2021 −4.44M USD. Net income FY2022 −2.88M USD. Net income FY2023 −3.4M USD. Net income FY2024 −4.48M USD. Net income FY2025 −3.75M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue5.64M USD7.74M USD7.35M USD8.34M USD7.75M USD
Cost of goods sold2.56M USD4.18M USD3.07M USD3.28M USD3.17M USD
Gross profit3.08M USD3.56M USD4.29M USD5.06M USD4.59M USD
Research and development289.9K USD290.68K USD491.8K USD352.24K USD572.7K USD
Selling, general, and administrative6.37M USD7.07M USD6.78M USD7.26M USD8.64M USD
Operating expenses6.93M USD7.66M USD7.64M USD7.94M USD9.51M USD
Interest income86.54K USD17.49K USD11.99K USD1.94K USD1.08K USD
Interest expense516.11K USD389.49K USD63.31K USD1.03K USD
Depreciation and amortization428.64K USD453.85K USD381.74K USD354.13K USD493.88K USD
Operating income−3.85M USD−4.1M USD−3.35M USD−2.88M USD−4.92M USD
Net income−3.75M USD−4.48M USD−3.4M USD−2.88M USD−4.44M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
36%
4 beats, 6 misses, 1 met estimate
Average EPS surprise
-138.61%
11 comparable reports
Latest EPS result
-0.05
Estimate -0.11 · Beat by 54.55%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.07-0.07-0.2-0.34Q2 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MetQ3 '26BeatQ4 '26Estimate
Q2 2025, reported Apr 2, 2025: actual -0.15, estimate 0.03, surprise -600.00%, Miss. Q2 2025, reported May 8, 2025: actual -0.03, estimate -0.15, surprise +80.00%, Beat. Q3 2025, reported Aug 14, 2025: actual -0.18, estimate -0.09, surprise -100.00%, Miss. Q4 2025, reported Nov 14, 2025: actual -0.06, estimate -0.03, surprise -100.00%, Miss. Q1 2026, reported Mar 31, 2026: actual -0.3, estimate -0.06, surprise -400.00%, Miss. Q2 2026, reported May 8, 2026: actual -0.12, estimate -0.12, surprise 0.00%, Met estimate. Q3 2026, reported Aug 14, 2026: actual -0.05, estimate -0.11, surprise +54.55%, Beat. Q4 2026, reported Nov 13, 2026: actual —, estimate -0.1, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates3.59M2.68M1.77M863.54KQ2 '25MissQ2 '25BeatQ3 '25MissQ4 '25MissQ1 '26MissQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q2 2025, reported Apr 2, 2025: actual 1.3M USD, estimate 3.4M USD, surprise -61.88%, Miss. Q2 2025, reported May 8, 2025: actual 1.58M USD, estimate 1.54M USD, surprise +2.57%, Beat. Q3 2025, reported Aug 14, 2025: actual 1.03M USD, estimate 1.8M USD, surprise -42.72%, Miss. Q4 2025, reported Nov 14, 2025: actual 2.01M USD, estimate 2.74M USD, surprise -26.59%, Miss. Q1 2026, reported Mar 31, 2026: actual 1.02M USD, estimate 2.31M USD, surprise -55.98%, Miss. Q2 2026, reported May 8, 2026: actual 1.65M USD, estimate 1.69M USD, surprise -2.12%, Miss. Q3 2026, reported Aug 14, 2026: actual 2.25M USD, estimate 1.84M USD, surprise +21.98%, Beat. Q4 2026, reported Nov 13, 2026: actual —, estimate 3.01M USD, surprise —, Comparison unavailable.

TOMZ peers

ETFs holding TOMZ

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research TOMZ

research.disclaimer